Dublin, October 28, 2020 (Global News)-ResearchAndMarkets.com’s products have added the “Hematology and Coagulation Market (Laboratory and Decentralized Market)” report.
The hematology and coagulation market (lab-based market and decentralized market) examines the status of two growing test markets. The report discusses COVID-19 related to hematology and coagulation markets. Several global health organizations and health professionals have reported the negative impact of COVID-19 on patients with blood diseases, including rare diseases such as sickle cell disease and thalassemia. Coagulation tests, including d-dimers, are considered to be a growing indicator of the impact and clinical outcome of COVID-19 patients. Several international organizations take the lead in determining and issuing recommendations and guidelines for the management of coagulopathy in COVID-19 patients. Hematology is the study of peripheral blood and bone marrow cells. The purpose is to diagnose various diseases of the blood, including leukemia, anemia, and autoimmune diseases. The hematology examination menu includes: CBC + 5 identifications (or 3 identifications), manual identification/inspection, hematocrit, hemoglobin (automatic, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count And analysis and red blood cell count (RBC). The inspection of the global hematology testing market includes analyzers/instruments and reagents: all commercial laboratory and hospital products, certain research products used in clinical laboratories, and OTC product sales (not testing services). The market data points provided include:
Hemostasis (coagulation) is a complex process in which a variety of enzymes and proteins regulate blood flow and blood clot formation. Blood coagulation (clot formation), fibrinolysis and platelet aggregation are part of this process. The requirements for hemostasis testing vary from laboratory to laboratory. Some facilities only perform routine preoperative tests (PT/INR and PTT), while other facilities also conduct professional tests (coagulation factors). In both cases, the steady increase in patient testing volume and the growing demand for rapid and reliable results require laboratories to seek solutions for hemostasis testing to provide consistent results and streamline workflows to improve efficiency. Based on the laboratory and all POCs use d-dimer as a market segment. Market data points presented:
Research and Marketing also provides customized research services to provide targeted, comprehensive and tailored research.
Post time: Feb-02-2021